| Product Code: ETC9918266 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in the UAE population |
4.2.2 Growing awareness and diagnosis of CNV among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CNV therapies |
4.3.2 Limited access to advanced CNV treatments in certain regions of the UAE |
5 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Trends |
6 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market, By Types |
6.1 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Number of CNV screening programs implemented in the UAE |
8.2 Percentage increase in early detection rates of CNV |
8.3 Adoption rate of novel CNV treatment technologies in UAE healthcare facilities |
9 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here